Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995;3(1):28-33.
doi: 10.1155/S1064744995000263.

Single-blind, prospective, randomized study of cefmetazole and cefoxitin in the treatment of postcesarean endometritis

Affiliations

Single-blind, prospective, randomized study of cefmetazole and cefoxitin in the treatment of postcesarean endometritis

A Chatwani et al. Infect Dis Obstet Gynecol. 1995.

Abstract

Objective: The purpose of this study was to compare the clinical efficacy and safety of cefmetazole given by IV push with that of parenterally administered cefoxitin for the treatment of endometritis following cesarean delivery.

Methods: In a single-blind, multicenter, prospective, randomized study, 355 patients with endometritis after cesarean delivery were enrolled and received medication. Administered was either cefmetazole sodium, 2 g by IV push over 1 min q 8 h, or cefoxitin sodium, 2 g IV q 6 h in a 2:1 ratio. The patients were followed for clinical responses and side effects.

Results: The cure rate for cefmetazole was 89% and for cefoxitin it was 79% (P = 0.006). The adverse events were similar in both groups.

Conclusions: Cefmetazole was significantly more effective than cefoxitin in the treatment of endometritis following cesarean delivery.

PubMed Disclaimer

References

    1. J Infect Dis. 1974 Sep;130(3):307-10 - PubMed
    1. CMAJ. 1993 Apr 1;148(7):1161-9 - PubMed
    1. J Reprod Med. 1990 Nov;35(11 Suppl):1070-7 - PubMed
    1. Am J Obstet Gynecol. 1975 Aug 1;122(7):891-901 - PubMed
    1. Surg Gynecol Obstet. 1990 Feb;170(2):137-40 - PubMed

LinkOut - more resources